iShares US Medical Devices ETF

IHI

Market cap $3.23B

I rate iShares US Medical Devices ETF a buy, as its recent selloff offers an attractive entry into industry-leading medical device innovators. IHI's top holdings—Abbott Laboratories, Intuitive Surgical, and Boston Scientific—drive growth through strong fundamentals, product innovation, and exposure to secular healthcare trends. Despite higher fees (0.38%) and volatility, IHI's concentrated exposure to medical devices positions it for long-term capital appreciation over more diversified healthcare ETFs.

Market volatility from Iran tensions has created dip-buying chances. Here are 5 ETFs across tech, semis, dividends, healthcare and financials.

Launched on May 1, 2006, the iShares U.S. Medical Devices ETF (IHI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Medical Devices segment of the equity market.

Over the past three years, healthcare has been among the worst-performing sectors. 2026's market rotation away from tech is bringing new life to more defensive areas of the market.

Designed to provide broad exposure to the Healthcare - Medical Devices segment of the equity market, the iShares U.S. Medical Devices ETF (IHI) is a passively managed exchange traded fund launched on May 1, 2006.

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Looking for broad exposure to the Healthcare - Medical Devices segment of the equity market? You should consider the iShares U.S. Medical Devices ETF (IHI), a passively managed exchange traded fund launched on May 1, 2006.

iShares U.S. Medical Devices ETF continues to underperform the S&P 500, hitting multi-year relative lows since 2012. IHI's valuation remains elevated with a P/E above 25x and a high PEG ratio, while earnings growth is modest at 9.6%. The ETF is highly concentrated, with its top 10 holdings comprising over 75% of the portfolio and a persistently low dividend yield.

Designed to provide broad exposure to the Healthcare - Medical Devices segment of the equity market, the iShares U.S. Medical Devices ETF (IHI) is a passively managed exchange traded fund launched on May 1, 2006.

iShares U.S. Medical Devices ETF offers targeted exposure to U.S. medical device leaders, benefiting from demographic shifts and innovation, but is highly concentrated in top holdings. Current valuation metrics (P/E 31x, P/B 4.6x) are too high; I recommend holding and waiting for a price drop before buying. Industry growth is fueled by an aging population and technological advances like AI and 3D printing, supporting a strong long-term outlook.